Liu Fang, Li Ting-hong, Han Tao, Xiang Hui-ling, Zhang Hong-sheng
Department of Hepatology, Tianjin Third Central Hospital; Institute of Hepatobiliary Disease; Tianjin Key Laboratory of Artificial Cell, Tianjin 300170, China.
Zhonghua Gan Zang Bing Za Zhi. 2013 Nov;21(11):840-4. doi: 10.3760/cma.j.issn.1007-3418.2013.11.010.
To investigate the clinical value of FibroScan transient elastography for assessing portal hypertension in liver cirrhosis patients by determining the relationship between the liver or spleen stiffness measurement with the imaging parameters of esophageal varices, portal vein width, spleen volume, and splenic vein width.
A total of 259 patients with liver cirrhosis underwent FibroScan measurement, ultrasound, computed tomography and routine blood analyses. One-hundred-and-one of those patients also underwent endoscopy to diagnose esophageal varices. Receiver operating characteristic (ROC) curves were generated and the areas under the curves (AUCs) were calculated to assess the accuracy of the FibroScan liver and spleen stiffness measurements to predict esophageal varices. Pearson's correlation analysis was used to assess the relationship between clinical features.
The median liver and spleen stiffness of the cirrhotic patients were 24.27 kPa and 44.64 kPa, respectively. Liver and spleen stiffness increased in conjunction with increases in Child-Pugh score. Liver stiffness was positively correlated with spleen stiffness (P less than 0.05). Liver and spleen stiffness were positively correlated with esophageal varices, portal vein width, spleen thickness, spleen volume, and splenic vein width. The correlation of spleen stiffness was higher than that of liver stiffness. Spleen stiffness was also negatively correlated with white blood cell count and platelet count. Liver and spleen stiffness also increased in conjunction with increased severity of esophageal varices. The AUC of spleen stiffness was higher than that of liver stiffness for predicting esophageal varices (0.804 vs. 0.737). The optimal cut-off level of spleen stiffness was 44.5 kPa (sensitivity: 88%; specificity: 68%). The estimated prevalence of esophageal varices was 97.87% and the optimized cut-off level of liver stiffness was 18.0 kPa.
FibroScan appears to be a clinically valuable non-invasive method to assess portal hypertension in cirrhotic patients. Both liver and spleen stiffness measurements correlated with portal hypertension but the spleen stiffness measurement may be of higher clinical value.
通过确定肝脏或脾脏硬度测量值与食管静脉曲张的影像学参数、门静脉宽度、脾脏体积和脾静脉宽度之间的关系,探讨FibroScan瞬时弹性成像在评估肝硬化患者门静脉高压中的临床价值。
对259例肝硬化患者进行FibroScan测量、超声、计算机断层扫描和常规血液分析。其中101例患者还接受了内镜检查以诊断食管静脉曲张。绘制受试者操作特征(ROC)曲线并计算曲线下面积(AUC),以评估FibroScan肝脏和脾脏硬度测量预测食管静脉曲张的准确性。采用Pearson相关分析评估临床特征之间的关系。
肝硬化患者的肝脏和脾脏硬度中位数分别为24.27 kPa和44.64 kPa。肝脏和脾脏硬度随Child-Pugh评分增加而升高。肝脏硬度与脾脏硬度呈正相关(P<0.05)。肝脏和脾脏硬度与食管静脉曲张、门静脉宽度、脾脏厚度、脾脏体积和脾静脉宽度呈正相关。脾脏硬度的相关性高于肝脏硬度。脾脏硬度还与白细胞计数和血小板计数呈负相关。肝脏和脾脏硬度也随食管静脉曲张严重程度增加而升高。脾脏硬度预测食管静脉曲张的AUC高于肝脏硬度(0.804对0.737)。脾脏硬度的最佳截断水平为44.5 kPa(敏感性:88%;特异性:68%)。食管静脉曲张的估计患病率为97.87%,肝脏硬度的优化截断水平为18.0 kPa。
FibroScan似乎是一种评估肝硬化患者门静脉高压的具有临床价值的非侵入性方法。肝脏和脾脏硬度测量均与门静脉高压相关,但脾脏硬度测量可能具有更高的临床价值。